Economic analysis of Innovo ® neuromuscular external electrical stimulation device for the treatment of stress urinary incontinence: A UK-based cost-utility analysis.

Conclusions: INNOVO® is a potentially cost-effective treatment option for patients with SUI who have failed first-line treatment. It could reduce costs to the health care service and improve quality-of-life for selected patients over their lifetime. PMID: 32468884 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - Category: Health Management Tags: J Med Econ Source Type: research